tamoxifen, Soltamox, Nolvadex (Discontinued) (cont.)

Pharmacy Author:
Medical and Pharmacy Editor:

Tamoxifen is associated with blood clots leading to deep vein thrombosis and pulmonary embolism.

Tamoxifen can cause abnormalities of liver tests, reduced white blood cells, red blood cells, and platelets. Reduced platelets can lead to bleeding. Patients should keep appointments for blood work to monitor for these side effects. Patients should report any suspected side effects immediately, especially bleeding and yellowing of the skin.

PRESCRIPTION: Yes

GENERIC AVAILABLE: Yes

PREPARATIONS: Tablets: 10 and 20 mg. Solution: 10 mg/5 ml

STORAGE: Tamoxifen should be stored in a dry place at 15 C - 30 C (59 F - 86 F).

DOSING: The dose for metastatic breast cancer treatment, DCIS, and prevention of breast cancer is 10 mg twice daily or 20 mg once daily for 5 years. The dose for stimulation of ovulation is 5-40 mg twice daily for 4 days. Tamoxifen can be taken with food.

DRUG INTERACTIONS: Tamoxifen increases the blood thinning effect of warfarin (Coumadin) and reduces blood levels of letrozole (Femara) and anastrozole (Arimidex). Phenobarbitol and rifampin may reduce blood levels of tamoxifen by increasing the breadkdown of tamoxifen.

PREGNANCY: Tamoxifen should not be used during pregnancy because it can harm the fetus.

NURSING MOTHERS: It is not known whether tamoxifen is excreted in breast milk. Tamoxifen causes a reduction in milk production. Women taking tamoxifen should not breastfeed.

Medically reviewed by Eni Williams, PharmD

Reference: FDA Prescribing Information


Medically Reviewed by a Doctor on 2/17/2015


Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index